These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31293182)

  • 21. Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab' fragments.
    Sapra P; Moase EH; Ma J; Allen TM
    Clin Cancer Res; 2004 Feb; 10(3):1100-11. PubMed ID: 14871990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are PEGylated liposomes better than conventional liposomes? A special case for vincristine.
    Wang X; Song Y; Su Y; Tian Q; Li B; Quan J; Deng Y
    Drug Deliv; 2016 May; 23(4):1092-100. PubMed ID: 26024386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HematoPorphyrin Monomethyl Ether polymer contrast agent for ultrasound/photoacoustic dual-modality imaging-guided synergistic high intensity focused ultrasound (HIFU) therapy.
    Yan S; Lu M; Ding X; Chen F; He X; Xu C; Zhou H; Wang Q; Hao L; Zou J
    Sci Rep; 2016 Aug; 6():31833. PubMed ID: 27535093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
    J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
    Krishna R; Webb MS; St Onge G; Mayer LD
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate.
    Zhang H; Wang ZY; Gong W; Li ZP; Mei XG; Lv WL
    Int J Pharm; 2011 Jul; 414(1-2):56-62. PubMed ID: 21596128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG
    Song XL; Liu S; Jiang Y; Gu LY; Xiao Y; Wang X; Cheng L; Li XT
    Eur J Pharm Sci; 2017 Jan; 96():129-140. PubMed ID: 27644895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature.
    Wang C; Zhao M; Liu YR; Luan X; Guan YY; Lu Q; Yu DH; Bai F; Chen HZ; Fang C
    Biomaterials; 2014 Jan; 35(4):1215-26. PubMed ID: 24231414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
    Salkho NM; Paul V; Kawak P; Vitor RF; Martins AM; Al Sayah M; Husseini GA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):462-472. PubMed ID: 29644867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temperature-controlled, phase-transition ultrasound imaging-guided photothermal-chemotherapy triggered by NIR light.
    Li W; Hou W; Guo X; Luo L; Li Q; Zhu C; Yang J; Zhu J; Du Y; You J
    Theranostics; 2018; 8(11):3059-3073. PubMed ID: 29896302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.
    Li M; Li Z; Yang Y; Wang Z; Yang Z; Li B; Xie X; Song J; Zhang H; Li Y; Gao G; Yang J; Mei X; Gong W
    Pharm Res; 2016 Aug; 33(8):1881-98. PubMed ID: 27075873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
    Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
    J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vincristine-sulphate-loaded liposome-templated calcium phosphate nanoshell as potential tumor-targeting delivery system.
    Thakkar HP; Baser AK; Parmar MP; Patel KH; Ramachandra Murthy R
    J Liposome Res; 2012 Jun; 22(2):139-47. PubMed ID: 22149643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug.
    Ling L; Ismail M; Du Y; Yao C; Li X
    Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near-infrared light-triggered drug release from a multiple lipid carrier complex using an all-in-one strategy.
    Li H; Yang X; Zhou Z; Wang K; Li C; Qiao H; Oupicky D; Sun M
    J Control Release; 2017 Sep; 261():126-137. PubMed ID: 28666728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma.
    Tokudome Y; Oku N; Doi K; Namba Y; Okada S
    Biochim Biophys Acta; 1996 Feb; 1279(1):70-4. PubMed ID: 8624364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
    Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
    Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes.
    Awad NS; Paul V; Mahmoud MS; Al Sawaftah NM; Kawak PS; Al Sayah MH; Husseini GA
    ACS Biomater Sci Eng; 2020 Jan; 6(1):48-57. PubMed ID: 33463192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel.
    Gu Z; Chang M; Fan Y; Shi Y; Lin G
    Colloids Surf B Biointerfaces; 2017 Dec; 160():395-405. PubMed ID: 28965079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.